339P AI-CROSS: Can artificial intelligence predict response to neoadjuvant chemoradiotherapy (CROSS) in gastro-oesophageal junction adenocarcinoma? A prospective randomized trial

ESMO Real World Data and Digital Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles